Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
Sector - Healthcare
Equity
-
Last updated on 2023-01-23
3Y returns
+26.46%
| ₹105.31 Latest NAV | ₹0.86 1D Change | ₹4563.40 AUM |
|---|---|---|
| Very High Risk Risk Profile | ₹100 Min SIP | ₹5000 Min Lumpsum |
| None Lock-in period | 1.11% Expense Ratio | 1.0% before 1 Months Exit Load |
Price Chart
+1.39 1Y return
Loading...
Top Holdings
Sun Pharmaceuticals Industries Ltd
14.39%
Dr Reddy's Laboratories Ltd
8.22%
Cipla Ltd
8.02%
Lupin Ltd
7.24%
Abbott India Ltd
6.06%
View All
Sector Breakdown
Healthcare
99.55%
Fund Manager
Sailesh Raj Bhan
Kinjal Desai
Akshay Sharma
Investment Objective
The Fund seeks to invest in pharma sector with focus on important
segments of the sector viz Domestic Business, International & CRAMS
and include deep value as well as high growth pharma businesses.
The fund invests across market capitalization within the sector. It may
suit investment horizon of around 2-3 years.
Download Scheme Document